Vesalio symposium - Cerebral vasospasm: Case Presentation

This LINNC Americas 2026 symposium features a case‑based presentation focused on the NeVa VS device from Vesalio. As the first and only FDA‑approved device indicated for the treatment of cerebral vasospasm, NeVa VS can be delivered through an O21 or O27 microcatheter and deployed using a standard pin‑and‑pull technique.

Charles Matouk presents his experience using this device for mechanical vasospasm treatment in a 30‑year‑old patient who developed progressive left‑sided weakness six days after an uneventful coiling procedure for a ruptured right MCA aneurysm. Santiago Ortega‑Gutierrez then discusses the case of a 56‑year‑old woman who developed severe symptomatic vasospasm, with confusion and left‑sided weakness, following endovascular treatment of two aneurysms.

Discover the complete treatment strategies involving NeVa VS and the clinical outcomes obtained in these challenging cases.

Sponsored by Vesalio